Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration

Hulse RP., Beazley-Long N., Ved N., Bestall SM., Riaz H., Singhal P., Ballmer Hofer K., Harper SJ., Bates DO., Donaldson LF.

<jats:p>Systemic treatment of diabetic rats with a novel human growth factor, vascular endothelial growth factor (VEGF)-A165b, reversed neuropathic pain and peripheral nerve damage.</jats:p>

DOI

10.1042/cs20150124

Type

Journal article

Journal

Clinical Science

Publisher

Portland Press Ltd.

Publication Date

01/10/2015

Volume

129

Pages

741 - 756

Permalink Original publication